400-0755-639
联系微信客服
最新产品
三叶新科每月上新,持续为科研人员提供新颖性研究工具,助力科研创新与突破。
首页 最新产品
RORγt Inverse agonist 10
目录号:SY-128533
RORγt Inverse agonist 10 is a highly potent and orally bioavailable compound that acts as an antagonist for the retinoic acid receptor-related orphan nuclear receptor gamma t (RORγt). With an IC50 of 51 nM, it effectively inhibits the activity of RORγt, a prominent transcription factor involved in the regulation of genes associated with the pathogenesis of psoriasis, including IL-17A, IL-22, and IL-23R.
¥1694.00
查看详情
BMS453
目录号:SY-128797
BMS453 (BMS-189453) 是一种合成类维生素 A,是一种 RARβ激动剂,也是一种 RARα/RARγ拮抗剂。它主要通过诱导活性 TGFβ 来抑制乳腺细胞生长。
¥495.00
查看详情
Amsilarotene
目录号:SY-128793
Amsilarotene (TAC101) 是口服有活性的合成类视黄醇,对视黄酸受体 α (RAR-α) 具有选择性亲和力,对 RAR-α 和 RAR-β 的 Ki=为 2.4 nM 和 400 nM。它可造成人胃癌、卵巢癌细胞及肝细胞癌的凋亡,可用于研究癌症。
¥561.00
查看详情
7β,27-dihydroxy Cholesterol
目录号:SY-128534
7β,27-dihydroxy Cholesterol is an oxysterol and agonist of retinoic acid receptor-related orphan receptor γ (RORγ) and RORγt. [1] It activates RORγ- or RORγt-dependent signaling with EC50 values of 691 and 1,045 nM, respectively, in reporter assays using HEK293T cells expressing the recombinant human receptors. 7β,27-dihydroxy Cholesterol is selective for RORγ and RORγt over a panel of eight additional nuclear receptors at 30 µM. It increases IL-17A production in Th17-polarized isolated human na ve CD4+ T cells when used at a concentration of 300 nM. 7β,27-dihydroxy Cholesterol (60 mg/kg) increases IL-17A production in isolated mouse γδ T cells stimulated with 12-myristate 13-acetate and ionomycin .
¥5742.00
查看详情
BMS 195614
目录号:SY-128799
BMS 195614 (BMS614)是一种选择性的RARα拮抗剂。BMS 195614可以与RARα亚基结合。
¥608.00
查看详情
Hexyl 4-hydroxybenzoate
目录号:SY-128540
Hexyl 4-hydroxybenzoate (Hexylparaben) 是一种视黄酸相关孤儿受体 RORγ(t) 的激动剂,EC50 为 144 nM,适用于研究自身免疫性疾病。
¥131.00
查看详情
Ch55
目录号:SY-128796
Ch55 (3,5-Di-tert-butylchalcone)是HL60细胞分化的有效诱导剂(EC50 = 200 nM),与RAR-α和RAR-β受体显示出高亲和力。Ch55可用于有关癌症的研究。
¥429.00
查看详情
TMP778
目录号:SY-128532
TMP778 is an effective and selective RORγt inverse agonist (IC50: 7 nM in FRET assay).
¥1584.00
查看详情
KCL-286
目录号:SY-128803
KCL-286是一种可口服且具有有效性的视黄酸受体β激动剂,可用于改善脊髓损伤(SCI)。
¥1848.00
查看详情